Stay updated on Talazoparib in DNA Repair Defects Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.

Latest updates to the Talazoparib in DNA Repair Defects Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the completed TALAPRO-1 talazoparib study is displayed, with its study design, eligibility criteria, locations, reported outcomes, publications, and supporting documents.SummaryDifference100%

- Check13 days agoChange DetectedThe site footer's displayed revision changed from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA new NIH website-transition notice appears above the 403 error page, and the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. This indicates an access restriction rather than an update to the study data.SummaryDifference18%

- Check61 days agoChange DetectedA new page revision label, Revision: v3.7.0, was added, replacing the previous Revision: v3.6.6. This signals an update to the page version rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Talazoparib in DNA Repair Defects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.